MEDIAN TECHNOLOGIES (EPA:ALMDT) | WebDisclosure

Basculer en Français

8295	Companies
114863	Keywords
55304	Articles
62446	Press releases

Home
Companies
MEDIAN TECHNOLOGIES

BRIEF

published on 10/30/2024 at 17:50, 21 days 19 hours ago

Median Technologies and AI in lung cancer screening

Artificial Intelligence Medical Technologies Lung Cancer Webconférence 2024 Medical Screening
BRIEF

published on 10/30/2024 at 17:50, 21 days 19 hours ago

Median Technologies et l'IA dans le dépistage du cancer du poumon

Intelligence Artificielle Cancer Du Poumon Technologies Médicales Dépistage Médical Webconférence 2024
PRESS RELEASE

published on 10/30/2024 at 17:45, 21 days 19 hours ago

Informations privilégiées / Autres communiqués
Median Technologies organise une webconférence sur l'Intelligence Artificielle dans le dépistage du cancer du poumon avec des leaders d'opinion. Étude REALITY eyonis™ LCS présentée le 7 novembre 2024.

Intelligence Artificielle Dépistage Median Technologies Cancer Du Poumon Webconférence
BRIEF

published on 10/07/2024 at 17:50, 1 month 13 days ago

Status of voting rights and capital of Median Technologies as of September 30, 2024

Voting Rights Capital Actions Median Technologies September 30, 2024
BRIEF

published on 10/07/2024 at 17:50, 1 month 13 days ago

État des droits de vote et du capital de Median Technologies au 30 septembre 2024

Capital Droits De Vote Actions Median Technologies 30 Septembre 2024
PRESS RELEASE

published on 10/07/2024 at 17:45, 1 month 13 days ago

Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Déclaration du nombre total de droits de vote et du nombre d'actions composant le capital de Median Technologies au 30 septembre 2024, conformément à la réglementation financière

Capital Déclaration Droits De Vote Réglementation Financière Median Technologies
BRIEF

published on 09/06/2024 at 17:50, 2 months 14 days ago

Modification des droits attachés aux catégories d'actions de Median Technologies

Capital Droits De Vote Actions Median Technologies Modification Des Droits
BRIEF

published on 09/06/2024 at 17:50, 2 months 14 days ago

Modification of the rights attached to the categories of shares of Median Technologies

Voting Rights Capital Actions Median Technologies Modification Of Rights
PRESS RELEASE

published on 09/06/2024 at 17:45, 2 months 14 days ago

Changes in the rights attaching to the classes of shares or securities
Median Technologies discloses total voting rights and shares as of August 31, 2024, in accordance with regulatory requirements. Company uses AI for cancer diagnoses and treatments globally

Voting Rights Shares AI Median Technologies Cancer Diagnosis
PRESS RELEASE

published on 09/06/2024 at 17:45, 2 months 14 days ago

Modification des droits attachés aux catégories d'actions
Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital de Median Technologies au 31 août 2024. En savoir plus sur leur activité et leur cotation

Capital Droits De Vote Cotation Communiqué De Presse Median Technologies

1 2 ... 4

Accesswire

Published on 11/21/2024 at 12:00, 55 minutes ago

Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 55 minutes ago

Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 25 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 52 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 55 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:35, 20 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 40 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 48 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 55 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 25 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived

Les Echos

Published on 11/21/2024 at 06:58, 5 hours 57 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 57 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 57 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 47 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 35 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE